Ad is loading...
NDVAF
Price
$0.02
Change
-$0.00 (-0.00%)
Updated
Jun 12 closing price
ZLSCF
Price
$0.64
Change
-$0.00 (-0.00%)
Updated
Nov 11 closing price
Ad is loading...

NDVAF vs ZLSCF

Header iconNDVAF vs ZLSCF Comparison
Open Charts NDVAF vs ZLSCFBanner chart's image
Indiva
Price$0.02
Change-$0.00 (-0.00%)
Volume$510.99K
CapitalizationN/A
ZYUS LIFE SCIENCES
Price$0.64
Change-$0.00 (-0.00%)
Volume$7K
CapitalizationN/A
NDVAF vs ZLSCF Comparison Chart
Loading...
View a ticker or compare two or three
VS
NDVAF vs. ZLSCF commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NDVAF is a Hold and ZLSCF is a Hold.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (NDVAF: $0.02 vs. ZLSCF: $0.64)
Brand notoriety: NDVAF and ZLSCF are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: NDVAF: 100% vs. ZLSCF: 418%
Market capitalization -- NDVAF: $3.51M vs. ZLSCF: $0
NDVAF [@Pharmaceuticals: Other] is valued at $3.51M. ZLSCF’s [@Pharmaceuticals: Other] market capitalization is $0. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NDVAF’s FA Score shows that 0 FA rating(s) are green whileZLSCF’s FA Score has 0 green FA rating(s).

  • NDVAF’s FA Score: 0 green, 5 red.
  • ZLSCF’s FA Score: 0 green, 5 red.
According to our system of comparison, ZLSCF is a better buy in the long-term than NDVAF.

Price Growth

NDVAF (@Pharmaceuticals: Other) experienced а 0.00% price change this week, while ZLSCF (@Pharmaceuticals: Other) price change was -0.89% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -5.07%. For the same industry, the average monthly price growth was -7.87%, and the average quarterly price growth was -11.90%.

Industries' Descriptions

@Pharmaceuticals: Other (-5.07% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

FUNDAMENTALS
Fundamentals
ZLSCF YTD gains are higher at: 9.271 vs. NDVAF (-67.266).
NDVAFZLSCFNDVAF / ZLSCF
Capitalization3.51MN/A-
EBITDA-5.09MN/A-
Gain YTD-67.2669.271-726%
P/E RatioN/AN/A-
Revenue34.9MN/A-
Total Cash2.82MN/A-
Total Debt21.9MN/A-
FUNDAMENTALS RATINGS
NDVAF: Fundamental Ratings
NDVAF
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
81
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RSI
ODDS (%)
Stochastic
ODDS (%)
Momentum
ODDS (%)
MACD
ODDS (%)
TrendWeek
ODDS (%)
TrendMonth
ODDS (%)
Advances
ODDS (%)
Declines
ODDS (%)
BollingerBands
ODDS (%)
Aroon
ODDS (%)
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JVASX43.07-0.04
-0.09%
JPMorgan Value Advantage I
HNISX13.95-0.02
-0.14%
Harbor International Small Cap Retire
TWQAX15.25-0.09
-0.59%
Transamerica Large Cap Value A
GTLIX25.46-0.41
-1.58%
Glenmede Quant US Large Cap Core EqInstl
RSMMX9.99-0.21
-2.06%
Victory RS Small Cap Equity Member

NDVAF and

Correlation & Price change

A.I.dvisor tells us that NDVAF and ZLSCF have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NDVAF and ZLSCF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NDVAF
1D Price
Change %
NDVAF100%
N/A
ZLSCF - NDVAF
25%
Poorly correlated
N/A
MEDIF - NDVAF
9%
Poorly correlated
-1.64%
MRMD - NDVAF
4%
Poorly correlated
-6.76%
OASMY - NDVAF
2%
Poorly correlated
N/A
NXEN - NDVAF
2%
Poorly correlated
N/A
More

ZLSCF and

Correlation & Price change

A.I.dvisor tells us that ZLSCF and HROW have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ZLSCF and HROW's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZLSCF
1D Price
Change %
ZLSCF100%
N/A
HROW - ZLSCF
26%
Poorly correlated
-8.98%
NDVAF - ZLSCF
25%
Poorly correlated
N/A
IXHL - ZLSCF
21%
Poorly correlated
-14.53%
TSNDF - ZLSCF
12%
Poorly correlated
+4.59%
PLNH - ZLSCF
9%
Poorly correlated
N/A
More